Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analyses
Abstract Background Shorter duration of symptoms before remdesivir has been associated with better outcomes. Our goal was to evaluate variables associated with the need of ICU admission in a cohort of hospitalized patients for COVID-19 under remdesivir including the period from symptoms onset to rem...
Main Authors: | Rodrigo Alonso-Navarro, Margarita Ramírez, Mar Masiá, Roger Paredes, Rocío Montejano, Marina Povar-Echeverria, Jordi Carratalà, Miguel Salavert, Enrique Bernal, Carlos Dueñas, Juan Flores, Francisco Fanjul, Isabel Gutiérrez, Verónica Rico, Lourdes Mateu, Julen Cadiñanos, Juan Berenguer, Alex Soriano |
---|---|
格式: | 文件 |
语言: | English |
出版: |
BMC
2023-05-01
|
丛编: | BMC Infectious Diseases |
主题: | |
在线阅读: | https://doi.org/10.1186/s12879-023-08222-y |
相似书籍
-
Remdesivir administration for SARS-CoV-2 pneumonia in ICU and non-ICU patients: outcome and posttreatment differences — the Italian Military Hospital experience
由: Antonio Sabba, et al.
出版: (2023-09-01) -
The effect of remdesivir on mortality and the outcome of patients with COVID‐19 in intensive care unit: A case–control study
由: Mehran Amirizadeh, et al.
出版: (2023-11-01) -
The use of Remdesivir in pregnant women with COVID-19
由: Gulbanu Shaimerdenova, et al.
出版: (2023-02-01) -
Remdesivir for coronavirus 2019 (COVID-19): More promising but still unproven
由: Richard D. Shih, et al.
出版: (2020-12-01) -
Publicaciones sobre hidroxicloroquina y remdesivir: actualización septiembre 2020
由: Flor álvarez de Toledo
出版: (2020-10-01)